Indian Journal of Urology Users online:1390  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non–Muscle-invasive Bladder Cancer in United States Clinical Practice
Kyle A. Richards,Shih-Wen Lin,Ching-Yi Chuo,Christina L. Derleth,Jingbo Yi,Marko Zivkovic,Sarika Ogale,Sandip Prasad,G. Joel Decastro,Gary D. Steinberg
Urology.2020;()
[DOI]
2Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
Mohamad Moussa,Athanasios G Papatsoris,Athanasios Dellis,Mohamed Abou Chakra,Wajih Saad
Expert Review of Anticancer Therapy.2020;()1
[DOI]
3The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
Ciro Andolfi,Jeffrey C. Bloodworth,Apostolos Papachristos,Randy F. Sweis
Bladder Cancer.2020;6(3)225
[DOI]
4Radical treatment of muscle-invasive bladder cancer—are options equal?
David Fackrell,Andrea Marshall,Pankaj Mistry,Janet Dunn,Maria De Santis,Daniel Ford,Anjali Zarkar
Journal of Radiation Oncology.2018;7(2)181
[DOI]
5Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
Agustina Bessa,Rebecca Martin,Christel Häggström,Deborah Enting,Suzanne Amery,Muhammad Shamim Khan,Fidelma Cahill,Harriet Wylie,Samantha Broadhead,Kathryn Chatterton,Sachin Malde,Rajesh Nair,Ramesh Thurairaja,Pardeep Kumar,Anna Haire,Saran Green,Margaret Northover,Karen Briggs,Mieke Van Hemelrijck
BMC Urology.2020;20(1)181
[DOI]
6Physical activity patterns and associations with health-related quality of life in bladder cancer survivors
Ajay Gopalakrishna,Thomas A. Longo,Joseph J. Fantony,Michael R. Harrison,Brant A. Inman
Urologic Oncology: Seminars and Original Investigations.2017;35(9)540.e1
[DOI]
7BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine
Omodele Ashiru,Gloria Esteso,Eva M. García-Cuesta,Eva Castellano,Celia Samba,Eva Escudero-López,Sheila López-Cobo,Mario Álvarez-Maestro,Ana Linares,Mei M. Ho,Asier Leibar,Luis Martínez-Piñeiro,Mar Valés-Gómez
Cancers.2019;11(7)940
[DOI]
8Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells
Tao Wu,Xi Duan,Chunyan Hu,Changqiang Wu,Xiaobin Chen,Jing Huang,Junbo Liu,Shu Cui
Artificial Cells, Nanomedicine, and Biotechnology.2019;47(1)512
[DOI]
9Formulation and characterization of EGCG for the treatment of superficial bladder cancer
Katarzyna Dettlaff,Maciej Stawny,Magdalena Ogrodowczyk,Anna Jelinska,Waldemar Bednarski,Dorota Watróbska-Swietlikowska,Rick W. Keck,Omar A. Khan,Ibrahim H. Mostafa,Jerzy Jankun
International Journal of Molecular Medicine.2017;40(2)329
[DOI]
10Active surveillance for nonmuscle invasive bladder cancer
Makito Miyake,Kiyohide Fujimoto,Yoshihiko Hirao
Investigative and Clinical Urology.2016;57(Suppl 1)S4
[DOI]
11Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer
Eman N. Khorshid,Mervat M.F. El Deftar,Ghada S. Osman
Egyptian Journal of Pathology.2017;37(2)352
[DOI]
12Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer
Tvrtko Hudolin,Zeljko Kastelan,Ahmad El-Saleh,Mirko Bakula,Marijana Coric,Petar Kes,Davor Tomas,Nikolina Basic-Jukic
Oncology Letters.2019;37(2)352
[DOI]
13Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer
Sanchia S. Goonewardene,Raj Persad,Hanif Motiwala,David Albala
Oncology Letters.2020;37(2)123
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us

HEALTHWARE INDIA